Rodica Busui, MD, PhD, is the Jordan Schnitzer-endowed chair in diabetes; professor and division head of endocrinology, diabetes, and clinical nutrition; director of the Harold Schnitzer Diabetes Health Center at the Oregon Health & Science University in Portland, OR; and professor emeritus at the University of Michigan.

Her research interests involve chronic complications of diabetes, including diabetes-related neuropathy, diabetes-related foot complications, cardiovascular disease, diabetes-related kidney disease, and novel technologies for diabetes management. She has been principle investigator (PI) and/or member of the Steering Committee in many landmark diabetes clinical trials, including ACCORD, DCCT/EDIC, PERL, BARI- 2D, GRADE, DEVOTE, REPLACE-BG, WISDM, MOBILE, SOUL. She is the chair of the NIDDK Diabetes Foot Consortium and a PI of Breakthrough T1D (former JDRF) Center of Excellence. She has also designed and leads several NIH- and industry-funded investigator-initiated studies to unveil disease-modifying agents for diabetes complications, and on the use of diabetes technologies to improve patients’ outcomes and diabetes care delivery.

Dr. Busui has published 350 peer-reviewed manuscripts and book chapters, as well as chaired the American Diabetes Association’s (ADA’s) 2017 Statement on Diabetic Neuropathy, the 2022 ADA/American College of Cardiology Heart Failure in Diabetes Consensus, and was the ADA’s 2023 president for medicine and science. She received awards for her research and advancement of diabetes care from many organizations, including the ADA, the European Association for the Study of Diabetes, the Fulbright Foundation, Harvard Medical School, the Romanian Diabetes Society, and the University of Michigan.